This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (51)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anthony du Vivier, MB, MRCP

Arch Dermatol. 1976;112(9):1245-1248.

Abstract
• Acute tolerance to the vasoconstrictive effect of topically applied glucocorticoids in humans has recently been described. Similar acute tolerance to the antiproliferative properties of topically applied steroids in proliferating and normal hairless mouse epidermis is now shown to occur. Thus, at first, topically applied steroids cause profound inhibition of DNA synthesis and mitosis in the epidermis, but with continued treatment, DNA synthesis and mitosis recover and the tissue becomes insensitive to further stimulation. This suggests that there is an optimum approach to therapy with topically applied steroids that might reduce the incidence of side effects and improve therapeutic efficacy.

(Arch Dermatol 112:1245-1248, 1976)

Author Affiliations
From the Division of Dermatology, Scripps Clinic and Research Foundation, La Jolla, Calif. Dr du Vivier is now at St Mary's Hospital, London.

Footnotes
Accepted for publication Nov 5, 1975.

Reprint requests to Department of Dermatology, St Mary's Hospital, London W2, England (Dr du Vivier).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical corticosteroids in atopic dermatitis
Atherton
BMJ 2003;327:942-943.
FULL TEXT  

Treatment of Psoriasis
Greaves and Weinstein
NEJM 1995;332:581-589.
FULL TEXT  

Are Topical Corticosteroids Useful Adjunctive Therapy for the Treatment of Psoriasis With Ultraviolet Radiation? A Review of the Literature
Meola et al.
Arch Dermatol 1991;127:1708-1713.
ABSTRACT  

Application of Topical Corticosteroids
Mortenhumer and Oikarinen
Arch Dermatol 1985;121:971-971.
ABSTRACT  

Topical Fluocinonide and Tachyphylaxis
Senter
Arch Dermatol 1983;119:363-364.
ABSTRACT  

Applications of Glucocorticosteroids: The Effects of Twice-Daily vs Once-Every-Other-Day Applications on Mouse Epidermal Cell DNA Synthesis
du Vivier et al.
Arch Dermatol 1982;118:305-308.
ABSTRACT  

Topical Drug Effects on Normal and Proliferating Epidermal Cell Models: Comparison With Responses in Psoriatics
Lowe et al.
Arch Dermatol 1981;117:394-398.
ABSTRACT